Chairman, President & CEO of Quest Diagnostics Inc. (DGX, Financial) Surya N Mohapatra sells 20,555 shares of DGX on 03/01/2011 at an average price of $56.75 a share.
Quest Diagnostics Inc. has a market cap of $9.53 billion; its shares were traded at around $56.08 with a P/E ratio of 14 and P/S ratio of 1.3. The dividend yield of Quest Diagnostics Inc. stocks is 0.7%. Quest Diagnostics Inc. had an annual average earning growth of 13.2% over the past 10 years. GuruFocus rated Quest Diagnostics Inc. the business predictability rank of 4.5-star.
Hedge Fund Gurus that owns DGX: Joel Greenblatt of Gotham Capital, Steven Cohen of SAC Capital Advisors, Bruce Kovner of Caxton Associates, Louis Moore Bacon of Moore Capital Management, LP. Mutual Fund and Other Gurus that owns DGX: Edward Owens of Vanguard Health Care Fund, Diamond Hill Capital of Diamond Hill Capital Management Inc, James Barrow of Barrow, Hanley, Mewhinney & Strauss, Robert Olstein of Olstein Financial Alert Fund, John Hussman of Hussman Economtrics Advisors, Inc., Jeff Auxier of Auxier Focus Fund, Jeremy Grantham of GMO LLC, Murray Stahl of Horizon Asset Management.
For the complete insider trading history of DGX, click here.
Quest Diagnostics Inc. has a market cap of $9.53 billion; its shares were traded at around $56.08 with a P/E ratio of 14 and P/S ratio of 1.3. The dividend yield of Quest Diagnostics Inc. stocks is 0.7%. Quest Diagnostics Inc. had an annual average earning growth of 13.2% over the past 10 years. GuruFocus rated Quest Diagnostics Inc. the business predictability rank of 4.5-star.
Hedge Fund Gurus that owns DGX: Joel Greenblatt of Gotham Capital, Steven Cohen of SAC Capital Advisors, Bruce Kovner of Caxton Associates, Louis Moore Bacon of Moore Capital Management, LP. Mutual Fund and Other Gurus that owns DGX: Edward Owens of Vanguard Health Care Fund, Diamond Hill Capital of Diamond Hill Capital Management Inc, James Barrow of Barrow, Hanley, Mewhinney & Strauss, Robert Olstein of Olstein Financial Alert Fund, John Hussman of Hussman Economtrics Advisors, Inc., Jeff Auxier of Auxier Focus Fund, Jeremy Grantham of GMO LLC, Murray Stahl of Horizon Asset Management.
CEO Recent Trades:
- Sell: Chairman, President & CEO Surya N Mohapatra sold 152,000 shares of DGX stock on 02/09/2011 at the average price of 57.53. Surya N Mohapatra owns at least 302,211 shares after this. The price of the stock has decreased by 2.52% since.
CFO Recent Trades:
- Sell: SVP & CFO Robert Hagemann sold 99,287 shares of DGX stock on 02/07/2011 at the average price of 58.92. Robert Hagemann owns at least 116,674 shares after this. The price of the stock has decreased by 4.82% since.
Directors and Officers Recent Trades:
- Sell: SVP & General Counsel Michael E Prevoznik sold 8,685 shares of DGX stock on 02/18/2011 at the average price of 57.46. Michael E Prevoznik owns at least 50,220 shares after this. The price of the stock has decreased by 2.4% since.
- Sell: SVP-Pathology & Hosp. Services Joan Elizabeth Miller sold 26,666 shares of DGX stock on 02/16/2011 at the average price of 57.4. Joan Elizabeth Miller owns at least 103,957 shares after this. The price of the stock has decreased by 2.3% since.
- Sell: SVP & General Counsel Michael E Prevoznik sold 19,997 shares of DGX stock on 02/15/2011 at the average price of 57.19. Michael E Prevoznik owns at least 41,028 shares after this. The price of the stock has decreased by 1.94% since.
- Sell: SVP & General Counsel Michael E Prevoznik sold 1,503 shares of DGX stock on 02/14/2011 at the average price of 57.17. Michael E Prevoznik owns at least 60,944 shares after this. The price of the stock has decreased by 1.91% since.
- Sell: Director John C Md Baldwin sold 30,000 shares of DGX stock on 02/09/2011 at the average price of 57.56. John C Md Baldwin owns at least 10,002 shares after this. The price of the stock has decreased by 2.57% since.
For the complete insider trading history of DGX, click here.
